LianBio Cash And Cash Equivalents At Carrying Value

Quick Answer

LianBio reported Cash And Cash Equivalents At Carrying Value of $79.22 million for the year ending 2022.

  • LianBio showed a decrease of -65.3% in Cash And Cash Equivalents At Carrying Value from 2021 to 2022.
  • This data is from LianBio's annual report (Form 10-K), filed with the SEC on March 28, 2023.
  • XBRL data for this metric is available from 2020 to 2022 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 3 years of available data (2020 to 2022), LianBio's Cash And Cash Equivalents At Carrying Value has declined by 68.9%.
  • Historical annual values: Fiscal year 2022: $79.22 million | Fiscal year 2021: $228.18 million | Fiscal year 2020: $254.35 million.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: